 The study found that patients who used three or more canisters of short acting beta agonist, Saba, medication per year were at a significantly higher risk of experiencing a severe asthma exacerbation. This suggests that these patients should be monitored closely by their physicians to ensure proper management of their condition. This article was offered by Stephen G. Nouduin, Christina Chen, Carissa M. Johnston, and others.